Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
HDA’s 2026 Healthcare Outlook Highlights the Industry’s Policy Priorities
Chain Drug Review, a pharmacy trade publication, published its annual “Healthcare Outlook” column by HDA President and CEO Chip Davis, which examines the industry’s priorities for 2026.
HDA Presents McKesson’s Brandon Miller With 2026 DMA for Industry Leadership
The Healthcare Distribution Alliance (HDA) today presented Brandon Miller, Vice President of Brand Strategic & Vaccine Sourcing at McKesson, with the 2026 Distribution Management Award (DMA) for Industry Leadership.
Faces of the Supply Chain: Distribution Sector Problem Solving and Cold Chain Capabilities
In the latest installment of HDA’s Faces of the Supply Chain series, HDA asked industry leaders to reflect on the role of healthcare distribution sector professionals as they navigate everyday challenges and adapt to evolving best practices as novel treatments emerge.
In part one of our two-part blog series, HDA is recapping the valuable perspectives shared during our conversations conducted at the 2024 Distribution Management Conference.
HDA and the HDA Research Foundation Name Governance Appointments
Today, the Healthcare Distribution Alliance (HDA) and the HDA Research Foundation announce the following governance updates.
Distributors Rising to the Challenge During the Coronavirus Pandemic
As the impact of COVID-19 “coronavirus” pandemic continues to unfold, we are all deeply concerned about our personal health and well-being — and that of our loved ones. As Americans worry about when their workplaces or schools will reopen, or if they have an adequate supply of necessary household staples, many also have heightened concerns about whether they will be able to access the vital medications and healthcare products they rely on each day.